Pacific Biosciences Of California reported $1.77B in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Accelerate Diagnostics AXDX:US USD 75.85M 17.12M
Agilent A:US USD 10.92B 387M
Bruker BRKR:US USD 3.62B 281.6M
Danaher DHR:US USD 84.35B 3.32B
Fluidigm FLDM:US USD 390.31M 24.6M
General Electric GE:US USD 187.79B 6.91B
Illumina ILMN:US USD 12.25B 996M
Myriad Genetics MYGN:US USD 1.2B 13.3M
Nanostring Technologies NSTG:US USD 353.41M 30.19M
Pacific Biosciences Of California PACB:US USD 1.77B 51.86M
Perkinelmer PKI:US USD 14.13B 303.09M
Quidel QDEL:US USD 8.86B 200.3M
Roche Holding ROG:VX 88.15B 1.42B
Thermo Fisher Scientific TMO:US USD 97.29B 6.75B
Waters WAT:US USD 3.28B 211.4M